Lessee, Operating Lease, Liability, to be Paid in USD of Sonnet BioTherapeutics Holdings, Inc. from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q1 2019 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2024 was $143,703, a 39.4% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $143,703 -$93,614 -39% 30 Sep 2024 10-K 17 Dec 2024 2024 FY
Q3 2023 $237,317 -$79,259 -25% 30 Sep 2023 10-K 14 Dec 2023 2023 FY
Q3 2022 $316,576 30 Sep 2022 10-K 15 Dec 2022 2022 FY
Q2 2022 $341,263 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q4 2019 $27,659,890 31 Dec 2019 10-K 19 Mar 2020 2019 FY
Q3 2019 $29,228,779 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $31,655,501 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $32,764,667 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.